Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | suppression of tumorigenicity 18 protein | 0.0066 | 0.0158 | 0.0158 |
Schistosoma mansoni | myelin transcription factor 1 myt1 | 0.0066 | 0.0158 | 0.0273 |
Mycobacterium tuberculosis | Probable transcriptional regulatory protein (probably LuxR/UhpA-family) | 0.0203 | 0.2885 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0514 | 0.9076 | 1 |
Echinococcus multilocularis | histone acetyltransferase MYST2 | 0.0066 | 0.0158 | 0.0158 |
Mycobacterium tuberculosis | Possible two component transcriptional regulatory protein (probably LuxR-family) | 0.0203 | 0.2885 | 0.5 |
Echinococcus granulosus | neuropeptide receptor A26 | 0.0561 | 1 | 1 |
Mycobacterium tuberculosis | Possible nitrate/nitrite response transcriptional regulatory protein NarL | 0.0203 | 0.2885 | 0.5 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.172 | 0.1895 |
Echinococcus multilocularis | endonuclease exonuclease phosphatase | 0.0227 | 0.3366 | 0.3366 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0052 | 0.0057 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.0052 | 0.0057 |
Mycobacterium tuberculosis | Probable transcriptional regulatory protein | 0.0203 | 0.2885 | 0.5 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.172 | 0.1895 |
Brugia malayi | C2-HC type zinc finger protein C.e-MyT1 | 0.0066 | 0.0158 | 0.0175 |
Echinococcus granulosus | histone acetyltransferase MYST2 | 0.0066 | 0.0158 | 0.0158 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.172 | 0.1895 |
Mycobacterium tuberculosis | Possible transcriptional regulatory protein | 0.0203 | 0.2885 | 0.5 |
Mycobacterium tuberculosis | Probable transcriptional regulatory protein (LuxR-family) | 0.0203 | 0.2885 | 0.5 |
Echinococcus multilocularis | suppression of tumorigenicity 18 protein | 0.0066 | 0.0158 | 0.0158 |
Echinococcus granulosus | endonuclease exonuclease phosphatase | 0.0227 | 0.3366 | 0.3366 |
Mycobacterium leprae | PROBABLE TRANSCRIPTIONAL REGULATORY PROTEIN | 0.0203 | 0.2885 | 0.5 |
Loa Loa (eye worm) | MBCTL1 | 0.0066 | 0.0158 | 0.0175 |
Schistosoma mansoni | hypothetical protein | 0.035 | 0.5814 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.0052 | 0.0057 |
Onchocerca volvulus | 0.0058 | 0 | 0.5 | |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.0052 | 0.0057 |
Brugia malayi | hypothetical protein | 0.0514 | 0.9076 | 1 |
Echinococcus multilocularis | neuropeptide receptor A26 | 0.0561 | 1 | 1 |
Echinococcus multilocularis | neuropeptide s receptor | 0.0561 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0066 | 0.0158 | 0.0175 |
Onchocerca volvulus | Polycomb protein Sfmbt homolog | 0.0058 | 0 | 0.5 |
Mycobacterium ulcerans | hydrolase/amidase | 0.0269 | 0.4209 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 13.1154 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Potency (functional) | 112.2018 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488939] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.